NCT02266875View on ClinicalTrials.gov

Nebulized Hypertonic Saline for Inpatient Use in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

70

Participants

Timeline

Start Date

October 31, 2014

Primary Completion Date

January 30, 2017

Study Completion Date

January 30, 2017

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

hypertonic saline

DRUG

standard saline

Trial Locations (1)

43228

Doctors Hospital, Columbus

Sponsors

Lead Sponsor

OhioHealth
All Listed Sponsors
lead

OhioHealth

OTHER

NCT02266875 - Nebulized Hypertonic Saline for Inpatient Use in COPD | Biotech Hunter | Biotech Hunter